Orbis Medicines
DenmarkEntry
2024
Hold
2yr
Status
Active
Who owns Orbis Medicines?
Orbis Medicines is a Danish Biotech company, currently owned by Eifo since 2025 and Novo Holdings.
Hand-verified · updated 2026-08-18
Open JSON · CC-BY
Most recent investor
Novo HoldingsNovo Holdings Seed Investments · 1999 · VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Novo HoldingsActive
2024 · present(2yr) · Novo Holdings Seed Investments · 1999 · VC
EifoActive
2025 · present(1yr) · EIFO (direct equity) · 1992 · VC
More from Novo Holdings Seed Investments
Other portfolio companies in the same fund.
US
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Orbis Medicines?
Orbis Medicines is currently owned by Eifo and Novo Holdings, through Novo Holdings Seed Investments, since 2025.
When did Eifo and 1 other acquire Orbis Medicines?
Eifo and 1 other acquired Orbis Medicines in 2025.
Who has owned Orbis Medicines over time?
Orbis Medicines has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2024; Eifo · via EIFO (direct equity) · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue